Corticosteroid Therapy for Drug-induced Liver Injury: Mind the Gap!

Journal of Hepatology · Published 2026-08-01 · DOI 10.1016/j.jhep.2026.07.023

Free full text

Authors (3)

Guruprasad P. Aithal, Sabine Weber, Hester Franks

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Aithal, G., Weber, S., Franks, H. (2026). Corticosteroid Therapy for Drug-induced Liver Injury: Mind the Gap!. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2026.07.023

Related articles

• Quantitative Bias Analysis of Unmeasured Confounding Refines Interpretation of Longitudinal Associations Between Cardiometabolic Risk Factors and Liver Stiffness in MASLD · Journal of Hepatology · 2026 · Same journal
• Updates in clinical science: Alcohol-related hepatitis · Journal of Hepatology · 2026 · Same journal
• Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction · Journal of Hepatology · 2026 · Same journal
• OSM-STAT3 signaling facilitates Long-term expansion of Pediatric Hepatic Organoids · Journal of Hepatology · 2026 · Same journal
• JHEP at a glance (August 2026) · Journal of Hepatology · 2026 · Same journal
• Before repurposing Fusobacterium nucleatum in alcohol-associated liver disease: it is a rare, non-resident organism in the human alcoholic gut · Journal of Hepatology · 2026 · Same journal
• Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort · Journal of Hepatology · 2026 · Same journal
• Non-selective β-blockers reduce bacterial translocation by restoring gut barrier function during experimental cirrhosis · Journal of Hepatology · 2026 · Same journal
• Metabolic dysfunction profiles identify heterogeneous hepatocellular carcinoma risk in MASLD-associated advanced fibrosis · Journal of Hepatology · 2026 · Same journal
• Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma · Journal of Hepatology · 2026 · Same journal